Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Repurchased
Ratios

Select Medical Holdings (SEM) EBIAT (2018 - 2025)

Select Medical Holdings (SEM) has disclosed EBIAT for 8 consecutive years, with $88.5 million as the latest value for Q4 2025.

  • On a quarterly basis, EBIAT rose 227.74% to $88.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $214.5 million, a 65.04% increase, with the full-year FY2025 number at $214.5 million, up 65.04% from a year prior.
  • EBIAT was $88.5 million for Q4 2025 at Select Medical Holdings, up from $28.8 million in the prior quarter.
  • In the past five years, EBIAT ranged from a high of $164.9 million in Q2 2021 to a low of -$69.3 million in Q4 2024.
  • A 5-year average of $62.2 million and a median of $61.6 million in 2022 define the central range for EBIAT.
  • Peak YoY movement for EBIAT: tumbled 167.58% in 2024, then surged 227.74% in 2025.
  • Select Medical Holdings' EBIAT stood at $26.6 million in 2021, then surged by 150.44% to $66.5 million in 2022, then surged by 54.07% to $102.5 million in 2023, then crashed by 167.58% to -$69.3 million in 2024, then soared by 227.74% to $88.5 million in 2025.
  • Per Business Quant, the three most recent readings for SEM's EBIAT are $88.5 million (Q4 2025), $28.8 million (Q3 2025), and $40.6 million (Q2 2025).